Triple-Negative Breast Cancer Risk in Women Is Defined by the Defect of Estrogen Signaling: Preventive and Therapeutic Implications

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s52600
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Therapeutic Landscape in Mutational Triple Negative Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Triple Negative Breast Cancer in Moroccan Women: Clinicopathological and Therapeutic Study at the National Institute of Oncology

BMC Women's Health
MedicineGynecologyReproductive MedicineObstetrics
2012English

Therapeutic Advances and New Directions for Triple-Negative Breast Cancer

Breast Care
SurgeryOncology
2017English

Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer

2012English

Triple-Negative Breast Cancer

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy